Literature DB >> 22342871

Relations of regulatory T cells with hepatitis markers in chronic hepatitis B virus infection.

Omnia El-Badawy1, Douaa Sayed, Mohamed S Badary, Mohamed E Abd-Alrahman, Mohamed A El-Feky, Amany G Thabit.   

Abstract

To assess regulatory T cells (Treg) in chronic hepatitis B (CHB) infected patients and to evaluate the presence of a possible relation between them and hepatitis B markers, flow cytometry analysis was carried out to calculate the percentages of Tregs, Tregs secreting IL-10 and CD4(+) T cells secreting interferon-γ (IFN-γ) and enzyme-linked immunosorbent assay was used to detect hepatitis B virus (HBV) markers in 59 patients and 32 healthy controls. CD4(+)CD25(+), CD4(+)CD25(+)Foxp3(+), CD4(+)D25(high), CD4(+)CD25(high)Foxp3(+) and CD4(+)CD25(-)Foxp3(+) T cells and Treg cells secreting IL-10 were higher in CHB patients than in healthy controls. CD4(+)CD25(+), CD4(+)CD25(-), and total CD4(+)T cells secreting IFN-γ were generally lower in CHB patients than in healthy controls. Fair correlations were observed between CD4(+)CD25(+)Foxp3(+) T cells and alanine aminotransferase (ALT) levels and between HBsAb and both CD4(+)CD25(+)Foxp3(+) and CD4(+)CD25(high)Foxp3(+) T cells. CD4(+)CD25(+) T cells were significantly higher in CHB virus infected patients positive for HBeAg than in those negative for HBeAg and a good correlation was observed between CD4(+)CD25(+) T cells and HBeAg. Fair negative correlations were observed between CD4(+)CD25(high) T cells and both HBeAb and HBcAb. These data suggest that Tregs contribute to viral persistence. It was not possible to say that Tregs were the cause of immune suppression in this group of patients.
Copyright © 2012 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22342871     DOI: 10.1016/j.humimm.2012.01.014

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  5 in total

1.  Downregulation of immunosuppressive environment in patients with chronic HBV hepatitis on maintained remission.

Authors:  Belal Chaudhary; Eyad Elkord
Journal:  Front Immunol       Date:  2015-02-11       Impact factor: 7.561

2.  Relationship of Treg/Th17 balance with HBeAg change in HBeAg-positive chronic hepatitis B patients receiving telbivudine antiviral treatment: A longitudinal observational study.

Authors:  Xiaoling Yang; Jia Li; Jie Liu; Min Gao; Li Zhou; Wei Lu
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

3.  Regulatory T cell frequencies and phenotypes following anti-viral vaccination.

Authors:  A Charlotte M T de Wolf; Susan van Aalst; Irene S Ludwig; Caroline L Bodinham; David J Lewis; Ruurd van der Zee; Willem van Eden; Femke Broere
Journal:  PLoS One       Date:  2017-06-28       Impact factor: 3.240

4.  CD4+CD25+CD127(low) Regulatory T Cells Play Predominant Anti-Tumor Suppressive Role in Hepatitis B Virus-Associated Hepatocellular Carcinoma.

Authors:  Shreya Sharma; Ritu Khosla; Paul David; Archana Rastogi; Ashish Vyas; Dileep Singh; Ankit Bhardwaj; Amrish Sahney; Rakhi Maiwall; Shiv Kumar Sarin; Nirupma Trehanpati
Journal:  Front Immunol       Date:  2015-02-25       Impact factor: 7.561

Review 5.  Regulatory T-cells promote hepatitis B virus infection and hepatocellular carcinoma progression.

Authors:  Wei Li; Jun Han; Hong Wu
Journal:  Chronic Dis Transl Med       Date:  2016-11-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.